XML 52 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock Incentive Plans (Tables)
12 Months Ended
Dec. 31, 2016
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Option, Unvested RSU Activity and Related Information (Detail)

The following table summarizes option and unvested RSU activity under the plans and related information:

 

 

 

Shares

Available

for Grant

 

 

Stock

Options

Outstanding

 

 

Weighted-

Average

Exercise

Price

 

 

Number of

RSU Shares

 

 

Weighted-

Average

Grant Date

Fair Value

 

Balance—December 31, 2013

 

 

332,995

 

 

 

466,965

 

 

$

1.99

 

 

 

 

 

$

 

Additional options authorized

 

 

940,884

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock grants

 

 

(4,899

)

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

(585,345

)

 

 

585,345

 

 

 

11.76

 

 

 

 

 

 

 

Assumed in business combination

 

 

 

 

 

23,229

 

 

 

2.06

 

 

 

 

 

 

 

Options exercised

 

 

 

 

 

(9,363

)

 

 

2.14

 

 

 

 

 

 

 

Options forfeited

 

 

20,591

 

 

 

(20,591

)

 

 

10.36

 

 

 

 

 

 

 

Options expired

 

 

13,781

 

 

 

(13,781

)

 

 

2.74

 

 

 

 

 

 

 

Balance—December 31, 2014

 

 

718,007

 

 

 

1,031,804

 

 

 

7.36

 

 

 

 

 

 

 

Additional options authorized

 

 

357,075

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock grants

 

 

(38,121

)

 

 

 

 

 

 

 

 

 

 

 

 

RSUs granted

 

 

(114,400

)

 

 

 

 

 

 

 

 

114,400

 

 

 

6.49

 

Options granted

 

 

(652,078

)

 

 

652,078

 

 

 

6.09

 

 

 

 

 

 

 

Options exercised

 

 

 

 

 

(23,576

)

 

 

1.94

 

 

 

 

 

 

 

RSUs forfeited

 

 

8,200

 

 

 

 

 

 

 

 

 

(8,200

)

 

 

6.49

 

Options forfeited

 

 

77,660

 

 

 

(77,660

)

 

 

8.13

 

 

 

 

 

 

 

Options expired

 

 

5,329

 

 

 

(5,329

)

 

 

10.36

 

 

 

 

 

 

 

Balance—December 31, 2015

 

 

361,672

 

 

 

1,577,317

 

 

 

6.87

 

 

 

106,200

 

 

 

6.49

 

Additional options authorized

 

 

512,575

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock grants

 

 

(61,921

)

 

 

 

 

 

 

 

 

 

 

 

 

RSUs granted

 

 

(287,900

)

 

 

 

 

 

 

 

 

287,900

 

 

 

5.50

 

Options granted

 

 

(597,470

)

 

 

597,470

 

 

 

4.91

 

 

 

 

 

 

 

Options exercised

 

 

 

 

 

(5,688

)

 

 

3.29

 

 

 

 

 

 

 

RSUs forfeited

 

 

61,305

 

 

 

 

 

 

 

 

 

(61,305

)

 

 

5.81

 

RSUs vested

 

 

 

 

 

 

 

 

 

 

 

(26,550

)

 

 

6.49

 

Options forfeited

 

 

269,212

 

 

 

(269,212

)

 

 

6.64

 

 

 

 

 

 

 

Options expired

 

 

107,601

 

 

 

(107,601

)

 

 

8.88

 

 

 

 

 

 

 

Balance—December 31, 2016

 

 

365,074

 

 

 

1,792,286

 

 

$

6.15

 

 

 

306,245

 

 

$

5.69

 

Vested at December 31, 2016

 

 

 

 

 

 

990,371

 

 

$

6.05

 

 

 

 

 

 

 

 

 

Vested and expected to vest at December 31, 2016

 

 

 

 

 

 

1,757,309

 

 

$

6.15

 

 

 

 

 

 

 

 

 

 

Schedule of Options Outstanding and Options Vested

Options outstanding and options vested as of December 31, 2016 are summarized as follows:

 

 

 

Options Outstanding

 

 

Options Vested

 

Range of

Exercise Prices

 

Number of

Options

Outstanding

 

 

Weighted

Average

Remaining

Contractual

Life (Years)

 

 

Weighted

Average

Exercise

Price

 

 

Number of

Options

Vested

 

 

Weighted

Average

Exercise

Price

 

$0.27 - 3.98

 

 

448,109

 

 

 

5.05

 

 

$

2.04

 

 

 

415,570

 

 

$

1.92

 

$4.37 - 4.60

 

 

179,263

 

 

 

9.15

 

 

 

4.47

 

 

 

18,064

 

 

 

4.46

 

$4.95 - 5.85

 

 

397,018

 

 

 

9.09

 

 

 

5.22

 

 

 

88,627

 

 

 

5.31

 

$6.49 - 7.03

 

 

384,910

 

 

 

8.18

 

 

 

6.64

 

 

 

189,136

 

 

 

6.64

 

$10.00 - 12.44

 

 

382,986

 

 

 

7.32

 

 

 

12.20

 

 

 

278,974

 

 

 

12.14

 

 

 

 

1,792,286

 

 

 

7.51

 

 

$

6.14

 

 

 

990,371

 

 

$

6.05

 

 

Summary of Options Outstanding and Exercisable Vested or Expected to Vest

Options outstanding that have vested and are expected to vest at December 31, 2016 are as follows:

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual Life

(Years)

 

 

Aggregate

Intrinsic

Value

(In thousands)

 

Vested

 

 

990,371

 

 

$

6.05

 

 

 

6.55

 

 

$

427

 

Expected to Vest

 

 

766,938

 

 

 

6.28

 

 

 

8.70

 

 

 

 

Total

 

 

1,757,309

 

 

$

6.15

 

 

 

7.49

 

 

$

427

 

 

 

Weighted-Average Assumptions Used to Fair Value of Share-Based Awards

The fair value of employee stock options and ESPP was estimated using the Black-Scholes Model using the following weighted-average assumptions.

 

 

 

 

Year Ended December 31,

 

 

 

 

2016

 

 

 

2015

 

 

 

2014

 

 

Employee Stock Options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expected term (in years)

 

 

5.9

 

 

 

 

6.0

 

 

 

 

5.1

 

 

Expected volatility

 

 

42.10

 

%

 

41.17

 

%

 

42.18

 

%

Risk-free interest rate

 

 

1.52

 

%

 

1.84

 

%

 

1.69

 

%

Expected dividend yield

 

 

%

 

 

%

 

 

%

Employee Stock Purchase Plan

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expected term (in years)

 

 

0.5

 

 

 

 

0.5

 

 

 

 

 

 

Expected volatility

 

77.05 – 90.81

 

%

 

39.10 – 44.15

 

%

 

 

 

 

Risk-free interest rate

 

0.37 – 0.49

 

%

 

 

0.11

 

%

 

 

 

 

Expected dividend yield

 

 

%

 

 

%

 

 

%

 

Summary of Expense Relating to Employee and Nonemployee Stock-Based Payment Awards from Stock Options and RSUs

The following table summarizes stock-based compensation expense relating to employee and nonemployee stock options, RSUs, and ESPP for the years ended December 31, 2016, 2015 and 2014, included in the statements of operations as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2016

 

 

2015

 

 

2014

 

Cost of testing

 

$

144

 

 

$

109

 

 

$

28

 

Research and development

 

 

449

 

 

 

247

 

 

 

88

 

Sales and marketing

 

 

156

 

 

 

173

 

 

 

29

 

General and administrative

 

 

1,249

 

 

 

812

 

 

 

390

 

 

 

$

1,998

 

 

$

1,341

 

 

$

535